New Cellgorithm™ data presented at ISSCR symposium indicates faster, scalable cell programming and add to Syntax Bio’s ...
Founder, will deliver a keynote titled "The Science of Sleeping: How Better Sleep Extends Healthspan," examining the ...
Felix Health today announced it will offer Galleri ®, GRAIL's multi-cancer early detection test, through its virtual care ...
Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2026. All results in this release reflect only ...
Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported ...
Tuesday, 3 November 2026 at 11.00 - 12.00am CET In connection with the publication of Coloplast’s financial results for FY ...
Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of ...
These data will be submitted to regulatory authorities in the U.S. by F2G and in Europe and Asia by Shionogi. F2G anticipates ...
Approval based on Phase 3 data showing unprecedented functional cure rates compared to standard of care – – Six-month ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical ...
(“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of ...
Hengrui Pharma continues to expand the clinical value of established products and advance its innovative pipeline, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results